- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Lithium Consolidation, Strongly Supported $3M Placement and Strategic Technology Demerger
S3N to restructure to focus on lithium and critical minerals exploration and re-brand as Premier1 Lithium, while privatising its minerals software and AI technology business
SensOre Ltd (‘SensOre’ or the ‘Company)’ is pleased to announce the acquisition of the 70% interest in Exploration Ventures AI Pty Ltd (‘EVAI’) it previously did not own, which includes the highly prospective Abbotts North lithium project.
Highlights
- SensOre board decides on strategic division of its exploration and technology assets by privatising its technology assets.
- SensOre Limited to propose rebranding as Premier1 Lithium Limited, emphasising its lithium and critical minerals exploration, pending shareholder consent.
- The Company has entered an agreement with joint-venture partner Deutsche Rohstoff AG for the acquisition of the 70% interest in lithium assets that SensOre did not already own via a scrip deal.
- The agreement coincides with a well-supported $3m placement to sophisticated and institutional investors to fund Premier1 Lithium and drilling of the Abbotts North lithium project, which has assays up to 1.25% Li2O (see below), as well as the wider lithium portfolio.
- The new technology company will operate as an independent, unlisted entity with new venture capital as discussions progress with a number of parties.
- The expectation is that once regulatory and shareholder approvals are in place, the in-specie distribution of shares in the technology company will be followed by the share issues to DR and placement investors.
- Current shareholders are entitled to the in-specie distribution of shares in the technology company and will retain their interest in the listed company to be renamed Premier1 Lithium.
- Premier1 Lithium will retain certain usage rights to the technology which has been instrumental in identifying our existing projects.
Abbotts North 100% SensOre Owned: 70% acquired by SensOre Scrip
The acquisition of the 70% interest in EVAI from its joint venture partner Deutsche Rohstoff AG is for 34.3 million shares in SensOre. Should the acquisition and the $3m share issue outlined below (together the ‘Lithium Transactions’) be approved by SensOre shareholders, Deutsche Rohstoff will hold 19.9% of SensOre. The acquisition includes three tranches of options. Series 1 consists of 6m options exercisable at $0.075; series 2 consists of 8m options exercisable at $0.088; and Series 3 consists of 12m options exercisable at $0.100. All tranches have an expiry of 3 years from the grant date.
Deutsche Rohstoff AG’s VP Geology, Ms Anja Ehser, will join the board as a non-executive director subject to shareholder approval.
Strongly supported $3m Placement to Institutional and Sophisticated Investors
SensOre is also pleased to announce that it has received binding commitments for $3m from new and existing institutional and sophisticated investors for the future exploration focused company in a placement Lead by PAC Partners Securities Pty Ltd (Pac Partners). Should the placement be approved by shareholders, new shareholders will own 34%. The funds will be used to advance early drilling on Abbotts North and the Company’s portfolio of lithium assets including Montague, Yalgoo and Gecko North.
PAC Partners acted as Lead Manager and Bookrunner to the placement (“Lead Manager”). The Lead Manager is entitled to receive 7.5m options exercisable at 10.5c with a three year expiry (subject to shareholder approval at the General Meeting); and 6% fee (plus GST where applicable) payable on the gross proceeds raised under the Placement.
Strategic Changes – SensOre to Change Name to Premier1 Lithium
SensOre will demerge its technology assets (‘Demerger Transaction’). The acquisition of EVAI and placement above are contingent on the technology demerger taking place. Subject to shareholder approval, SensOre has committed to the demerger of the technology assets by 31 January. SensOre has attracted significant interest from a number of strategic investors in the technology company.
As a consequence of the acquisition and demerger, SensOre intends to rebrand as Premier1 Lithium.
Further, the board has resolved to reduce the number of directors to three (3), a number more appropriate for the new strategic direction. As a result, Mr Robert Peck AM, Mr Adrian Manger, Mr Anthony O’Sullivan and Mr Robert Rowe have indicated they intend to submit their resignations.
Conditions Precedent
The Lithium Transactions and the Demerger Transaction are directly or indirectly conditional on the following:
(a) Shareholder approval of the demerger of the technology assets via in-specie distribution and capital reduction; the issue of shares to Deutsche Rohstoff AG for 70% of EVAI; and the issue of the placement shares;
(b) SensOre receiving binding commitments for at least $3m under the placement;
(c) Regulatory and ASX approvals; and
(d) Completion of the Demerger.
If any of the conditions precedent are not satisfied, the Lithium Transactions and the Demerger Transaction may not be able to proceed on the current timeframe. In the event that shareholders do not approve of the transaction, or third parties do not extend the timeframes in the agreements (in the event that time extensions are required), the Lithium Transactions and the Demerger Transaction will not proceed.
ASX and Regulatory Approvals
SensOre will seek advice from ASX on the application of relevant Listing Rules and S3N’s listing at the ASX post- demerger will be subject to receiving relevant confirmations from ASX.
SensOre is pleased to advise that it has received a waiver to Listing Rule 7.24A that allows escrowed shareholders to participate in the in-specie distribution subject to the condition that the shares distributed in- specie are subject to the same escrow period expiring on 11 February 2024.
General Meeting of SensOre Shareholders
SensOre will issue a notice of meeting to procure the shareholder approvals necessary to give effect to these transactions. The meeting is anticipated to be held on or about 17 January 2024. A Notice of Meeting will be dispatched to shareholders by 19 December 2023 being more than 28 days prior to the GM date.
Click here for the full ASX Release
This article includes content from SensOre, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
HighCom Limited Receives A$5.6m SUAS Spare Parts Order from Defence
HighCom Limited (ASX: HCL, ‘HighCom’, ‘Group’) is pleased to announce that it has received a new spare parts order for A$5.6m (including GST) from the Commonwealth of Australia’s Department of Defence, as part of the Small Uncrewed Aerial Systems (SUAS) Support Contract. The order will be completed during H2 FY2025.
- New A$5.6m (including GST) SUAS Spare Parts order received from Defence.
- Spare Parts will support AeroVironment SUAS previously acquired by Defence through HighCom Limited.
- Order will be completed in H2 FY25.
- Order is part of the multi-year Support Contract for AeroVironment SUAS announced by HighCom Limited on 3 October 2023.
This Support Contract has an initial 4-year term for support services with 6 years (2+2+2) of contract extension options. Contracted support services can include a variety of engineering, maintenance, and logistic support services, as well as the supply of spare parts. The order is part of the multi-year Support Contract for AeroVironment SUAS announced by HighCom Limited on 3 October 2023.
Mr Ben Harrison, HighCom Limited Chairman said:
“HighCom has been supporting Defence for over 30 years and is very pleased to receive this spare parts order under the initial 4-year term of the potential 10 year SUAS Support Contract for the mixed fleet of AeroVironment SUAS. HighCom remains committed to representing, delivering, integrating, and sustaining all AeroVironment product lines for the Australian Defence Force. This is backed by our decade of partnering with AeroVironment to introduce into service new and existing technologies to increase ADF capability.”
Click here for the full ASX Release
This article includes content from HighCom Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here
Opyl Signs New Service Agreement with Commercial Eyes
Opyl Limited (ASX: OPL) a leader in clinical trial design and biostatistical validation, is pleased to announce the signing of a service agreement with Commercial Eyes Pty Ltd, a ProductLife Group company and prominent Australian pharmaceutical and medical device commercialisation company.
Commercial Eyes is a leading lifesciences consultancy that offers full end-to-end commercialisation services. As part of ProductLife Group, an international leader in the life sciences industry, Commercial Eyes has expanded its global presence, enabling broader market access and expertise across the JAPAC region and beyond.
This collaboration will leverage global insights to enhance Commercial Eyes’ market research and competitive intelligence capabilities.
This agreement signifies a major milestone in Opyl's ongoing commitment to enhancing clinical trial outcomes through AI-driven solutions.
Under the terms of this agreement, Opyl will provide Commercial Eyes with market research, and competitive intelligence analysis to assist in a range of client projects, across the pharmaceutical, medtech and biotechnology sectors.
Key Highlights
- AI-Driven Clinical Trial Information: The service agreement enables Commercial Eyes to utilise Opyl’s TrialKey platform, which provides data-backed recommendations and boasts over 92% accuracy in forecasting clinical trial outcomes.
- Comprehensive Services: The paid partnership covers market research, and competitive intelligence analysis to support Commercial Eyes in offering strategic insights to its clients in the pharmaceutical and medical device sectors.
- International Exposure: Commercial Eyes, as part of the ProductLife Group (PLG), extends Opyl’s reach to international markets, particularly across Europe and the JAPAC region.
- Increased Domestic Exposure: The partnership also increases Opyl’s presence in the domestic market by leveraging Commercial Eyes’ strong reputation and client base within the Australian healthcare sector.
- Strategic Market Positioning: TrialKey’s data analytics empower Commercial Eyes to navigate the complex trial landscape, providing their clients with informed, strategic guidance that enhance commercial positioning and success.
Click here for the full ASX Release
This article includes content from Opyl, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
Next-generation Hadrian X® Completes US Site Acceptance Testing
Robotic technology company FBR Limited (ASX: FBR; OTCQB: FBRKF) (‘FBR’ or ‘the Company’) is pleased to announce that it has received confirmation from CRH Ventures that the first next-generation Hadrian X® has successfully met their requirements and has completed Site Acceptance Testing at the Fort Myers facility in Florida, United States.
Highlights
- FBR receives confirmation from CRH Ventures that first next-generation Hadrian X® successfully completes Site Acceptance Testing at Fort Myers facility in Florida
- Confirmation received from an independent structural engineer that the structure is consistent with design requirements and meets applicable building standards
- FBR to receive next tranche of non-refundable payment from CRH Ventures of US$600,000 under Demonstration Program agreement
- Construction of the first house in the Demonstration Program to commence shortly
An independent structural engineer provided confirmation that the walls of the test build were consistent with the design and met applicable building standards.
Completion of Site Acceptance Testing triggered a US$600,000 payment by CRH Ventures to FBR and the commencement of the Demonstration Program. The Demonstration Program requires FBR to construct the external walls of five to ten single-storey houses utilising the next-generation Hadrian X®. The Demonstration Program will commence shortly.
The Demonstration Program will be deemed complete when FBR completes construction of its five houses plus up to five houses added to the program by CRH Ventures, with all houses to be certified by an independent structural engineer. Upon completion of the Demonstration Program, FBR will receive a payment of US$400,000 from CRH Ventures under the Demonstration Program agreement. The completion of the Demonstration Program also marks the commencement of a 45-day period for CRH Ventures to exercise the option to form a joint venture for the delivery of Wall as a Service® in the United States.
This announcement has been authorised for release to the ASX by the FBR Board of Directors.
Click here for the full ASX Release
This article includes content from FBR Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
Cypher Metaverse Inc. Announces Financing
Cypher Metaverse Inc. (CSE:CODE) ("CODE" or the "Company") is pleased to announce that it is undertaking a non-brokered private placement of up to $1,000,000. The Company will issue up to 11,764,705 units at a price of $0.085 per unit. Each unit consists of one common share and one common share warrant. Each warrant entitles the holder to subscribe for one additional common share for $0.15 for a period of 2 years from the date of closing, subject to the Corporation's option to accelerate the expiry date if the stock trades at $0.20 for 10 trading days.
The Company has completed the first closing of the private placement. The Company accepted subscriptions for 1,357,061 units at a price of $0.085 per unit, for gross proceeds of $115,350. Securities issued pursuant to this tranche are subject to trading restrictions until December 7, 2024.
The Company intends to use the net proceeds of the Offering for general working capital and to finance the acquisition of Agape Luxury Goods Inc., as previously announced.
The Company may pay qualified finders fees of up to 8% in cash and 8% in brokers warrants.
About Cypher Metaverse Inc.
Cypher Metaverse Inc. seeks early-stage investments in emerging technology sectors, including the blockchain ecosystem, fintech and the metaverse. The Company identifies such opportunities and applies its relationships and capital to advance its interests.
The Company's head office is located at 1780-355 Burrard Street, Vancouver, BC, V6C 2C8. The common shares of CODE ("CODE Common Shares") are currently listed on the CSE and CODE is a reporting issuer in the provinces of British Columbia, Alberta and Ontario.
For further information please contact:
Cypher Metaverse Inc.
Brian Keane - Director
Phone: Toll-Free (877) 806-CODE (2633) or 1 (778) 806-5150
Neither the CSE nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this press release.
US Markets Rebound as Biden Drops Re-election Bid, Gold Price Drops Below US$2,400
The American stock market rebounded on Monday (July 22) following significant downturns last week, and after Sunday's (July 21) news that US President Joe Biden will not seek re-election.
Biden announced on social media platform X, formerly Twitter, that he is exiting the presidential race, and endorsed Vice President Kamala Harris as his replacement. He plans to complete his term as president.
By midday, the Dow Jones Industrial Average (INDEXDJX:.DJI) was up 0.36 percent, reaching 40,433.02 points. Meanwhile, the S&P 500 (INDEXSP:.INX) had increased by 0.86 percent to hit 5,552.57 points, and the Nasdaq Composite (INDEXNASDAQ:.IXIC) had climbed 1.23 percent to come in at 17,944.98 points.
Major technology stocks led the recovery, with Alphabet (NASDAQ:GOOGL), Microsoft (NASDAQ:MSFT), Apple (NASDAQ:AAPL) and Tesla (NASDAQ:TSLA) all posting gains of between 1 and 4.2 percent.
The US dollar index, which measures the greenback against six major currencies, rose for the third session in a row. Analysts believe the dollar's strength is partly due to anticipation of potential shifts in US fiscal and monetary policy.
Meanwhile, the gold price declined to a one week low as the dollar strengthened. Spot gold dropped by 0.5 percent to US$2,387.99 per ounce, while US gold futures decreased by 0.4 percent to US$2,389.40.
Investors are closely watching for additional US economic data and statements from Federal Reserve officials this week, which could provide further insight into the future direction of interest rates.
Jeffrey Christian, managing partner at CPM Group, told Reuters that the market is in "wait-and-see mode" regarding the implications of the change in the Democratic Party’s candidate for the upcoming election.
“It is far too early for any strategic positions… longer-term is probably more favorable for gold if Trump is in the White House," StoneX analyst Rhona O'Connell opined in a note quoted by Reuters.
"Trump would be inflationary and potentially incendiary in geopolitical terms, while Harris' foreign affairs policy is as yet undefined so that favours gold for now, but not possibly in the longer term,” she added.
Key data releases this week include US gross domestic product figures for the second quarter, and the personal consumption expenditures price index, which is the Fed's preferred inflation gauge.
Don't forget to follow us @INN_Technology for real-time updates!
Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.
Biden Administration Pledges Half a Billion for Tech Hubs in Underserved Communities
The Biden administration on Tuesday (July 2) announced plans to allocate US$504 million to establish 12 regional technology and innovation hubs across underserved regions in the US.
Spearheaded by the US Department of Commerce’s Economic Development Administration, the initiative aims to spur America's leadership in cutting-edge industries, create new jobs and stimulate economic development.
"Every American deserves the opportunity to thrive, no matter where they live,” underscored Vice President Kamala Harris in a press release. “Today’s announcement will ensure that the benefits of the industries of the future — from artificial intelligence and clean energy, to biotechnology and more — are shared with communities that have been overlooked for far too long, including rural, Tribal, industrial, and disadvantaged communities,” she added.
Funded by the CHIPS and Science Act, the Tech Hubs Program is part of President Joe Biden’s Investing in America agenda. A total of US$10 billion over five years has been authorized for this initiative, with US$541 million used to date.
Tech Hubs Program to support diverse initiatives
The Illinois Fermentation and Agriculture Biomanufacturing Tech Hub (iFAB), one recipient of the Tech Hubs Program, will receive approximately US$51 million. Led by the University of Illinois Urbana-Champaign, a land-grant research university, iFAB focuses on converting underutilized corn feedstock into high-value products like alternative proteins and food ingredients, while aiming to provide specialized training to the local workforce.
Other tech hubs will focus on quantum information technology in Colorado, autonomous remote sensing technology in Montana, biotechnology and biomanufacturing in Indiana and sustainable polymer manufacturing in Ohio.
Additional recipients include: the Nevada Tech Hub, which aims to build a full lithium lifecycle cluster; the NY SMART I-Corridor Tech Hub in New York, which focuses on enhancing regional semiconductor manufacturing capabilities; and the ReGen Valley Tech Hub in New Hampshire, which is looking to become a leader in biofabrication to produce cost-effective regenerative therapies addressing chronic disease and organ failure.
The SC Nexus for Advanced Resilient Energy in South Carolina has honed its efforts on advanced energy and grid resilience technologies, while the South Florida ClimateReady Tech Hub aims to advance leadership in sustainable and resilient infrastructure solutions for the global climate crisis. Meanwhile, the Tulsa Hub for Equitable & Trustworthy Autonomy in Oklahoma is working on the development and commercialization of autonomous systems for use in the agriculture industry, as well as in pipeline inspections and regional transportation.
Finally, the Wisconsin Biohealth Tech Hub aims to position the state as a global leader in personalized medicine, focusing on tailored tests, treatments and therapies informed by a patient's unique attributes.
Each hub will leverage regional assets to foster technological advancement and economic growth, with the expectation of creating new job opportunities at various skill levels.
Don't forget to follow us @INN_Technology for real-time updates!
Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.
Latest News
Latest Press Releases
Related News
TOP STOCKS
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.